Global Hair Transplant Market

Global Hair Transplant Market

Global Hair Transplant Market Research Report 2020, Segment by Key Companies, Countries, Types, Applications and Forecast 2021 to 2026

According to HJ Research’s study, the global Hair Transplant market is estimated to be valued at XX Million US$ in 2019 and is projected to reach XX Million US$ by 2026, expanding at a CAGR of XX% during the forecast period.

The report on the Hair Transplant market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Hair Transplant.

Key players in the global Hair Transplant market include:

Bernstein Medical
Bosley
Ethics hair instruments
MEDICAMAT
Restoration Robotics
Market segmentation, by product types:
Follicular Unit Transplantation (FUT)
Follicular Unit Extraction (FUE)

Market segmentation, by applications:

Hospitals
Clinics

Market segmentation, by regions:

North America (United States, Canada)
Europe (Germany, France, UK, Italy, Russia, Spain, Netherlands, Switzerland, Belgium)
Asia Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Vietnam)
Middle East & Africa (Turkey, Saudi Arabia, United Arab Emirates, South Africa, Israel, Egypt, Nigeria)
Latin America (Brazil, Mexico, Argentina, Colombia, Chile, Peru)

Reasons to get this report:

In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Hair Transplant market share analysis of high players, along with company profiles, and which collectively include the fundamental opinions regarding the market landscape, emerging and high-growth sections of Hair Transplant market, high-growth regions, and market drivers, restraints, and also market chances.

The analysis covers the Hair Transplant market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Hair Transplant Market across sections such as also application and representatives.

Additionally, the analysis also has a comprehensive review of the crucial players on the Hair Transplant market together side their company profiles, SWOT analysis, latest advancements, and business plans.

The report provides insights on the following pointers:

1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Hair Transplant industry.
2. Global major manufacturers’ operating situation (sales, revenue, growth rate and gross margin) of the Hair Transplant industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, Netherlands, Switzerland, Belgium, China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Vietnam, Turkey, Saudi Arabia, United Arab Emirates, South Africa, Israel, Egypt, Nigeria, Brazil, Mexico, Argentina, Colombia, Chile, Peru) market size (sales, revenue and growth rate) of Hair Transplant industry.
4. Different types and applications of Hair Transplant industry, market share of each type and application by revenue.
5. Global market size (sales, revenue) forecast by regions and countries from 2020 to 2026 of the Hair Transplant Industry.
6. Upstream raw materials and manufacturing equipment, downstream major consumers, industry chain analysis of Hair Transplant industry.
7. Key drivers influencing market growth, opportunities, the challenges and the analysis of the risk of the Hair Transplant industry.
8. New Project Investment Feasibility Analysis of Hair Transplant industry.

Global Hair Transplant Market Research Report 2020, Segment by Key Companies, Countries, Types, Applications and Forecast 2021 to 2026

Source

Recent Posts

Men and Women Hair Loss Market

Men and Women Hair Loss Market

Global Men and Women Hair Loss Market 2021 by Company, Regions, Type and Application, Forecast to 2026

The Men and Women Hair Loss market report provide a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Men and Women Hair Loss size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Men and Women Hair Loss market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

The men and Women Hair Loss market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Hair Loss and Growth Devices

Shampoos and Conditioners

Medicine Product

Market segment by Application can be divided into

Men

Women

Market segment by players, this report covers

Procter & Gamble

L’Oreal

Unilever

Taisho

Henkel

Merck

Shiseido

Johnson & Johnson Consumer Inc.

Rohto

Lifes2Good

Gerolymatos International

Toppik

Nanogen

Oxford BioLabs Ltd.

Ultrax Labs

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of the Middle East & Africa)

The content of the study subjects includes a total of 12 chapters:

Chapter 1, describe Men and Women Hair Loss product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, profile the top players of Men and Women Hair Loss, with revenue, gross margin and global market share of Men and Women Hair Loss from 2019 to 2021.

Chapter 3, the Men and Women Hair Loss competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021. and Men and Women Hair Loss market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, describe Men and Women Hair Loss research findings and conclusion, appendix and data source.

Global Men and Women Hair Loss Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Source

Recent Posts

Global Alopecia (Hair Loss Treatment) Market

Global Alopecia Market

Global Alopecia (Hair Loss Treatment) Market

Industry Growth Insights published new data on the “Alopecia (Hair Loss Treatment) Market”. The research report is titled “Alopecia (Hair Loss Treatment) Market research by Types (Shampoos and Conditioners, Medicine Product), By Applications (Men, Women), By Players/Companies Shiseido, Rohto, Unilever, Taisho, Angfa, LOreal, Kaminomoto, Merck, Yanagiya Honten, Amorepacific, Procter & Gamble, Himalaya, Gerolymatos International, Merz Pharma, Leader Teck, Vasu Healthcare, VLCC, Ales Group, Shanxi Ante, Wansheng Pharmaceutical, Advanced Skin and Hair, Humanwell Healthcare, Topfond, Lifes2good, Bawang, YNK Pharmaceutical, Apollo, Jingxiutang, Rogaine, Marico”. As per the latest research Alopecia (Hair Loss Treatment) market is expected to expand at a CAGR of xx% in the forecast period.

Scope Of The Report

Report Attributes
Report DetailsReport Title

Alopecia (Hair Loss Treatment) Market Research Report

By Type

Shampoos and Conditioners, Medicine Product

By Application

Men, Women

By Companies

Shiseido, Rohto, Unilever, Taisho, Angfa, LOreal, Kaminomoto, Merck, Yanagiya Honten, Amorepacific, Procter & Gamble, Himalaya, Gerolymatos International, Merz Pharma, Leader Teck, Vasu Healthcare, VLCC, Ales Group, Shanxi Ante, Wansheng Pharmaceutical, Advanced Skin and Hair, Humanwell Healthcare, Topfond, Lifes2good, Bawang, YNK Pharmaceutical, Apollo, Jingxiutang, Rogaine, Marico

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2020

Historical Year

2018 to 2019 (Data from 2010 can be provided as per availability)

Forecast Year

Global Alopecia (Hair Loss Treatment) Industry Outlook

Global Alopecia (Hair Loss Treatment) Market Report Segments:

The global Alopecia (Hair Loss Treatment) market is segmented on the basis of:

Types

Shampoos and Conditioners, Medicine Product

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights into the market. Furthermore, it discusses the latest product developments & innovation in the market.

Applications

Men, Women

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and the driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

Shiseido
Rohto
Unilever
Taisho
Angfa
LOreal
Kaminomoto
Merck
Yanagiya Honten
Amorepacific
Procter & Gamble
Himalaya
Gerolymatos International
Merz Pharma
Leader Teck
Vasu Healthcare
VLCC
Ales Group
Shanxi Ante
Wansheng Pharmaceutical
Advanced Skin and Hair
Humanwell Healthcare
Topfond
Lifes2good
Bawang
YNK Pharmaceutical
Apollo
Jingxiutang
Rogaine
Marico

Global Alopecia (Hair Loss Treatment) Market Overview

Highlights of The Alopecia (Hair Loss Treatment) Market Report:

The market structure and projections for the coming years.
Drivers, restraints, opportunities, and current trends of Alpha Hydroxy Acid for Cosmetic Market.
Historical data and forecast.
Estimations for the forecast period 2028.
Developments and trends in the market.
By Type:

Shampoos and Conditioners
Medicine Product

By Application:

Men
Women

Market scenario by region, sub-region, and country.
Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Alopecia (Hair Loss Treatment) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

Regional Analysis

North America
Europe
Asia Pacific
Middle East & Africa
Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

Correctly Positioning New Products
Market Entry Strategies
Business Expansion Strategies
Consumer Insights
Understanding Competition Scenario
Product & Brand Management
Channel & Customer Management
Identifying Appropriate Advertising Appeals

Global Alopecia (Hair Loss Treatment) Market Statistics

 

8 Reasons to Buy This Report

Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
Implemented Robust Methodology to Prepare the Report
Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
Provides Information About the Top-winning Strategies Implemented by Industry Players.
In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
Customization of the Report Available

Global Alopecia (Hair Loss Treatment) Market

Source

Recent Posts

Derma-IRON

Derma-IRON

Advanced Trichology Releases First-of-its-Kind Ingestible, Derma-IRON

On the heels of a year where Advanced Trichology saw 124% growth, founder and certified trichologist William Gaunitz, WTS, is introducing his most innovative ingestible yet – Derma-IRON. Developed in conjunction with dermatologist Dr. Brooke Blumetti, Derma-IRON features Ferrochel iron paired with 50mg of natural vitamin C from cherry juice to increase absorption plus 200mg of marine collagen.

Derma-IRON is the first iron supplement designed specifically for hair and nails. When the body is iron deficient, one way it reserves its stores is to grow less hair. The most at potential risk for hair loss by way of low iron are women aged 17-33 who experience heavy menstrual cycles, vegetarians, O and B blood types and others who have chronic low iron or ferritin levels. Additionally, low iron levels may cause increased fatigue, brittle nails, pale skin, tongue inflammation, and dizziness.

Ferrochel’s high potency iron is clinically researched, possesses little to no risk of gastrointestinal distress, has a low rate of adverse food interactions due to its fully soluble nature and is recognized by the US FDA as Generally Recognized As Safe (GRAS). Derma-IRON’s core ingredients are mindfully paired together to optimize iron stores in the body for maximum positive outcomes.

  • Ferrochel Iron: Preserving vital bodily functions, iron supports gut health, cognitive health, and hair and scalp health.
  • Vitamin C: Derived from cherry juice, the ascorbic acid is positive for being anti-inflammatory and helps increase iron absorption.
  • Marine Collagen: Having superior bioavailability, it can help repair skin cartilage and health, thicken the outer skin surface, increase skin firmness, grow nails, reduce wrinkles, improve sleep, and support gut health.

“I’ve been in the trichology industry for over 20 years, and I’m thrilled to bring to market one of the most innovative and functional products yet. Anything I create under the Advanced Trichology umbrella has been born out of seeking a solution for clients and Derma-IRON is no exception. An influx of young women seeking advice on their hair loss led me to really dive into the root cause of why this demographic was suddenly exploding with a hair loss or thinning issue. The culprit was unanimously dangerously low iron,” says William Gaunitz, WTS, certified trichologist and founder of Advanced Trichology. “Derma-IRON is multifaceted to replenish, repair and reinvigorate health. In accordance with the rest of the Advanced Trichology collection, Derma-IRON features ingredients that can be found in nature along with eco-friendly capsules and packaging.”

“Ferritin, a protein necessary for iron storage, is a critical requirement for proper hair growth. In cases of low iron and ferritin, I recommend the Derma-IRON supplement by Advanced Trichology to increase iron and boost ferritin because of its research-based ingredients and gentle impact on the gut,” said Brooke Blumetti DO, board-certified dermatologist at Affiliated Dermatology.

“I’m impressed with how Advanced Trichology continues to innovate with each new offering. From the ingredients to the packaging, Derma-IRON is a winner and a much-needed product on the market. I’m looking forward to seeing what William does next,” said Jeffery Rapaport, MD, FAAD, board-certified dermatologist and founder of Cosmetic Skin and Surgery Center.

Derma-IRON will retail for $29.95/one-month supply and be available for purchase at http://www.AdvancedTrichology.com.

Advanced Trichology Releases First-of-its-Kind Ingestible, Derma-IRON

Source

Recent Posts

Global Hair Transplant Industry

Hair Transplant Market Size

Hair Transplant Market Size And Forecast

Hair Transplant Market is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2020 to 2027.

The Global Hair Transplant Market report provides a holistic evaluation of the market for the forecast period. The report comprises various segments as well as an analysis of the trends and factors that are playing a substantial role in the market.

These factors; the market dynamics involve the drivers, restraints, opportunities, and challenges through which the impact of these factors in the market is outlined. The drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.

The Global Hair Transplant Market study provides an outlook on the development of the market in terms of revenue throughout the prognosis period.

What is Hair Transplant?

Hair transplant surgery involves removing small pieces of hair-bearing scalp grafts from a donor site and relocating them to a bald or thinning area. The procedure is primarily used to treat male pattern baldness. Hair transplants are typically more successful than over-the-counter (OTC) hair restoration products.

Global Hair Transplant Market Outlook

In the report, the market outlook section mainly encompasses fundamental dynamics of the market which include drivers, restraints, opportunities and challenges faced by the industry. Drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.

The hair transplant market is majorly driven by increasing number of surgical procedures and rising consumption of high doses of drugs. Moreover, technological advances in hair transplant procedures and changing lifestyle of individuals are some other factors expected to fuel the market growth. On the flip side, adverse drug side effects, high costs of treatment and lack of reimbursement policies and insurance coverage are the factors that might impede the market growth.

Verified Market Research narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements which interests the client. The “Global Hair Transplant Market” is mainly bifurcated into sub-segments which can provide a classified data regarding latest trends in the market.

Global Hair Transplant Market Competitive Landscape

The “Global Hair Transplant Market” study report will provide a valuable insight with an emphasis on global market including some of the major players such as Restoration Robotics, MEDICAMAT, CAPILLUS, Bernstein Medical, Cole Instruments Inc., Harris FUE Instruments, LaserCap Company, Apira Science, HairMax Inc., and Shaanxi Xingmao Industry Co. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Hair Transplant Market, By Surgical Method

• Follicular Unit Transplantation (FUT)
• Follicular Unit Extraction (FUE)
• Others

Hair Transplant Market, By Surgery Type

• Head Hair Transplant
• Eyebrow Transplant
• Frontal Hairline Lowering or Reconstruction
• Others

Hair Transplant Market, By End-User

• Trichology Clinics
• Hospitals
• Dermatologic Clinics
• Others

Hair Transplant Market Geographic Scope

• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Rest of Asia Pacific
• Rest of the World

Hair Transplant Market Size And Forecast

Source

Recent Posts

CTP-543 for Alopecia Areata

CTP-543 for Alopecia Areata

Concert Pharmaceuticals Initiates THRIVE-AA2 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia Areata

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced it has initiated THRIVE-AA2, the second planned Phase 3 clinical trial to evaluate the efficacy and safety of CTP-543, an oral Janus kinase inhibitor, in adult patients with moderate to severe alopecia areata. The Company expects to report topline results from THRIVE-AA2 in the second half of 2022. Under current timelines, the Company believes that positive results from two Phase 3 trials could serve as the basis for submitting a New Drug Application to the U.S. Food and Drug Administration (FDA) in early 2023 for CTP-543 for the treatment of moderate to severe alopecia areata in adult patients.

“We expect the CTP-543 THRIVE-AA clinical program to provide the pivotal data needed to support our registration,” said James V. Cassella, Ph.D., Chief Development Officer of Concert Pharmaceuticals. “The continued support of the alopecia areata community has been essential in progressing our program, and the initiation of this second Phase 3 trial brings us another step closer to seeking FDA-approval. We are hopeful that CTP-543 will be one of the first FDA-approved treatments for alopecia areata and will offer an important therapeutic option for this challenging autoimmune disease.”

“Alopecia areata can bring disruption and burden to daily life. But with the progress of clinical trials, there’s hope for patients,” said Thea Chassin, the Founder and Chief Executive Officer of Bald Girls Do Lunch Inc., an alopecia areata advocacy, education and support nonprofit. “We’re grateful for Concert’s research on behalf of the alopecia areata community. We applaud Concert’s goal to develop a potential new medication.”

About the THRIVE-AA2 Study

THRIVE-AA2 (NCT04797650) is a randomized, double-blind, placebo-controlled clinical trial in adult patients with moderate to severe alopecia areata at sites in the U.S., Canada and Europe evaluating the regrowth of scalp hair after 24 weeks of dosing using the Severity of Alopecia Tool (SALT). Key aspects of THRIVE-AA2 include:

  • Patient characteristics: adults age 18-65 years with ≥ 50% hair loss are eligible for the study;
  • Expected enrollment size: approximately 440 patients;
  • Dosing: 8 mg or 12 mg of CTP-543 or placebo twice-daily for 24 weeks; and
  • Primary endpoint: Percent of patients achieving a SALT score ≤ 20 at Week 24.

For more information about the THRIVE-AA1 and THRIVE-AA2 studies, please visit www.clinicaltrials.gov.

About CTP-543 and Alopecia Areata

CTP-543 is an oral selective inhibitor of Janus kinases JAK1 and JAK2. The FDA has granted CTP-543 Breakthrough Therapy designation for the treatment of adult patients with moderate to severe alopecia areata and Fast Track designation for the treatment of alopecia areata.

Alopecia areata is an autoimmune disease in which the immune system attacks hair follicles, resulting in partial or complete loss of hair on the scalp and body. Alopecia areata may affect up to 1 million Americans at any given time1. The scalp is the most commonly affected area, but any hair-bearing site can be affected alone or together with the scalp. The onset of the disease can occur throughout life and affects both women and men. Alopecia areata can be associated with serious psychological consequences, including anxiety and depression. There are currently no drugs approved by the FDA for the treatment of alopecia areata.

The FDA selected alopecia areata as one of eight new disease areas that it focused on under its Patient-Focused Drug Development Initiative (PFDDI) in 2016-2017. The goal of the PFDDI is to bring patient perspectives into an earlier stage of product development. Following the FDA’s Patient-Focused Drug Development meeting held in September 2017 on alopecia areata, the FDA summarized the input shared by patients and patient representatives in a Voice of the Patient report. Additional information on the PFDDI is available online.

About Concert

Concert Pharmaceuticals is a clinical stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform® (deuterated chemical entity platform). Selective incorporation of deuterium into known molecules has the potential, on a case-by-case basis, to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Concert’s lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates.

Concert Pharmaceuticals Initiates THRIVE-AA2 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia Areata

Source

Recent Posts

Global OTC Hair Loss Treatments Market

Global OTC Hair Loss Treatments Market

Global OTC Hair Loss Treatments Market

The OTC Hair Loss Treatments is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period.

The research provides insights for the global OTC Hair Loss Treatments market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the OTC Hair Loss Treatments industry.

For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global OTC Hair Loss Treatments Market Segmentations:

By Players:

  • Merck
  • J&J
  • Taisho Pharma
  • Costco Wholesale
  • Wal-Mart
  • Bayer
  • Zhejiang Wansheng Pharma
  • Sichuan Medco Huakang Pharma
  • Zhendong Anter
  • DrFormulas
  • Renata
  • DrRPFLEGER
  • DS Healthcare Group

By Types:

  • Minoxidil
  • Procapil
  • Other

By End-User:

  • Male
  • Female

By Regions:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • UK
  • France
  • Italy
  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)
  • Spain
  • Belgium
  • Poland
  • Russia
  • Turkey
  • Others

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia and New Zealand
  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)
  • Brazil
  • Nigeria
  • South Africa
  • Argentina
  • Others

Global OTC Hair Loss Treatments Market

Source

Recent Posts

Alopecia Market Size And Forecast

Alopecia Market Size And Forecast

Alopecia Market Size And Forecast

Alopecia Market was valued at USD 2.68 Billion in 2020 and is projected to reach USD 4.89 Billion by 2028, growing at a CAGR of 7.9% from 2021 to 2028.

Changing lifestyle ad rising prevalence of androgenic and areata alopecia across the globe is primary factors for driving growth of Global Alopecia Market. Also, the rise in disposable income of the people and growing awareness regarding alopecia treatment is fueling the growth of Global Alopecia Market. The Global Alopecia Market report provides a holistic evaluation of the market. The report offers comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Alopecia Market Definition

Alopecia areata is also called as spot baldness. It is a medical condition in which hair is lost from some or all areas of the body. Often it results in few bald spots on the scalp of the people. Generally size of spot is of coin. In few cases all the hair on the scalp or the body may lose for permanent.

Alopecia areata can be considered as an autoimmune disorder resulting from a breach in the immune privilege of the hair follicles. Risk factor for alopecia areata includes family history of the same medical condition. The mechanism involves failure by the body to recognize its own cells due to destruction of the hair follicle.

Till now there is no cure for the condition but some medications are tried for regrowth such as cortisone injection, sunscreen to protect the area being affected from cold and sun, glass if incase eyelashes has affected or missing. Another type alopecia andrgenetic which is common in the gender, in men such condition is also recognized as male-pattern baldness.

In this case hair is lost in well-defined manner. After some time hairline foam characteristic ‘M’ which is often progressing to the partial or complete baldness.in case of female it is different condition then male. In women, hair becomes thinner than normal from all over the head and often it further leads to total baldness. Androgenetic alopecia in men’s is resulted from some medical conditions such as coronary heart disease, enlargement of prostate, hypertension and many others.

Global Alopecia Market Overview

Changing lifestyle such as immoderate intake of alcohol and tobacco, and growing stress indices among the people are considered as major factor for rising prevalence of alopecia. Though the epidemiology of the disease is unknown, the genetic factor is considered as a one of the cause and linked to several cases of alopecia. In addition, rise in disposal income of the people and building emphasis on aesthetics are poised to drive the market growth of alopecia product.

Furthermore, aging and anomalies also boosting demand for alopecia treatment. Ender also plays important role in disease susceptibility. As per American Hair Loss Association, around 95% of the hair loss in men is due to androgenic alopecia and awareness among consumers is fueling the growth of Global Alopecia Market.

Moreover, rising prevalence of chronic disorders such as Polycystic Ovary Disease (PCOD), hyperthyroidism, acute stress disorder, hypothyroidism, cancer, lupus, and hypopituitarism are influencing the Global Alopecia Market.

New drug and technologies developments in the field such as emergence of rapid-action JAK inhibitors and hair growth stimulation through PRP treatment and pluripotent stem cells are accelerating the growth of Global Alopecia Market. However, high cost of treatment and lack of awareness in underdeveloped countries are anticipated to restrict the growth of Global Alopecia Market. Nevertheless, launch of new products and technologies are expected to generate new opportunities for the Global Alopecia Market during forecasted period.

Global Alopecia Market Segmentation Analysis

Global Alopecia Market is segmented based on Disease Type, Sales Channel, Gender, End-User, And Geography.

Alopecia Market, By Disease Type

• Alopecia areata
• Androgenetic alopecia
• Others

Based on Disease Type, Alopecia Market is segmented as Alopecia areata, Androgenetic alopecia and others. Alopecia areata sement is expected to hold largest share in the Alopecia Market. The growth is contributed to the high disease prevalence across the globe and increasing consumer awareness regarding treatments. Also, alopecia is most prevalent in the people who are suffering from autoimmune disorders. Androgenetic alopecia segment is expected to grow at fastest pace due to launch of multiple promising pipeline candidates and significant growth in the incidence rate.

Alopecia Market, By Sales Channel

• OTC
• Prescriptions

Based on Sales Channel, Alopecia Market is bifurcated into OTC and Prescriptions. Among these two segments, Prescriptions segment is expected to hold largest share in the alopecia market by sales channels. Various factors that are driving the growth of segments are cost effective treatment, easy accessibility of therapies and increasing number of approvals for medications.

Alopecia Market, By Gender

• Male
• Female

Based on Gender, Alopecia Market is bifurcated into Male and Female. Among these two segments, male segment are dominating the Alopecia Market, By Gender as androgen is leading cause of androgenic alopecia in men also, and increasing geriatric population across the globe and increasing tobacco intake by people are fueling the growth of male segment.

Alopecia Market, By End-User

• Homecare setting
• Dermatology clinics

Based on End-User, Alopecia Market is bifurcated into Homecare setting and Dermatology clinics. Among these two, Dermatology clinics segment is dominating the market. The growth is attributed to the increasing number of hair transplantation, and restoration surgeries. Homecare settings segment is also growing due to broadening penetration of laser treatment and rise in regulatory sanctions of homecare products.

Alopecia Market, By Geography
  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

On the basis of Geography, the Global Alopecia Market is classified into North America, Europe, Asia Pacific, and Rest of the world. North America is expected to hold largest market share due to growing advancement in the technology, novel product development and increasing disposal income of the people in the region is fueling the growth of alopecia market in the region. Asia-Pacific is expected to grow at fastest pace over the next few years. Large population base and growing consumer awareness regarding treatments are expected to boost the growth of alopecia market in the region.

Key Players in Alopecia Market

The “Global Alopecia Market” study report will provide a valuable insight with an emphasis on global market including some of the major players such as Sun Pharmaceutical Industries Ltd., Merck & Co., Inc., Cipla Inc., Johnson and Johnson AG, Lexington International LLC, Transitions Hair Pty Ltd., Cirrus Hair Centers, Vita-Cos-Med Klett-Loch GmbH, Capillus, and Follica, Inc.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Alopecia Market Size And Forecast

Source

Recent Posts

Dandruff Treatment Market

Dandruff Treatment Market

Global Dandruff Treatment Market

Market Analysis and Insights: Global Dandruff Treatment Market

The dandruff treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.8% in the forecast period of 2021 to 2028 and is expected to reach USD 11.915.15 million by 2028 from USD 7,645.23 million in 2020.

Increasing awareness regarding the scalp condition and growing urbanization, availability of various dandruff treatment substitutes is the key drivers of the market for global dandruff treatment market.

Dandruff is a scalp issue that is recognized by the presence of corneocytes that have the ability to shape groups. These bunches are white to yellowish scales and cause tingling at influenced zone. Dandruff generally influences during adolescence to middle age stage as this is the stage when sebaceous organ is at the exceptionally dynamic stage. There are different causes related to dandruff in which Malassezia furfur, a growth turns into the ruling element. Also, bacterial development over the scalp harms the scalp layer corneum.

Dandruff treatment products hence target these microbes in several ways. Zinc pyrithione is used in most of anti-dandruff products as it has anti-fungal activity. The other antifungal drugs indicated for dandruff treatment are ketoconazole, climbazole, selenium sulphide among others. Herbal products used for dandruff treatment are herbal oils that include tea tree oils, rosemary oil, lemon oil, neem, basil, cedarwood among others.

The demand for dandruff treatment has been increased in both developed as well as in developing countries and the reason behind this is the increasing number of malassezia species in the environment. The dandruff treatment market is growing due to the introduction of innovative products, increasing e-commerce of hair care products and rising disposable income. The market will grow in the forecasted period due to exploration of emerging markets, strategic initiatives by market players and increasing awareness regarding hair problems.

The dandruff treatment market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Dandruff Treatment Market Scope and Market Size

The global dandruff treatment market is categorized into eight notable segments which are based on basis of type, mode of prescription, product, drug type, age group, gender, end-user and distribution type.

  • On the basis of type, the dandruff treatment market is segmented into fungal dandruff, dry skin-related dandruff, oily scalp-related dandruff, disease-related dandruff. In 2021, fungal dandruff is dominating the market as a fungus called Malassezia is considered to be the main cause of dandruff. Although dandruff can be caused by several simultaneous reasons, the level of a fungus is one of the strongest contributing factors. A large number of dandruff treatment products aimed at restoring the microbiome of the scalp and hence controlling the fungus.
  • On the basis of mode of prescription, the dandruff treatment market is segmented into OTC, prescription. In 2021, OTC mode is dominating the market as most of the dandruff treatment products can be used at home without any prescription. These products are used over the skin and do not enter the body, making them safe for self-supervision. The easy availability of these products also attributes to the high share of OTC products in the dandruff treatment market.
  • On the basis of product, the dandruff treatment market is segmented into non-medicated, medicated. In 2021, non-medicated products are dominating in the global dandruff treatment market as more than 50% of adults are affected by this transient condition that does not cause any significant medical conditions. Most of the products for dandruff treatment are available over-the-counter and prove effective in controlling the symptoms.
  • On the basis of drug type, the dandruff treatment market is segmented into branded, generics. In 2021, branded products are dominating the global dandruff treatment market as most of the products constitute shampoos and oils manufactured by well-known global companies. Due to significant product promotion, consumer awareness is very high for several products making the branded products more common.
  • On the basis of age group, the dandruff treatment market is segmented into adults, paediatrics, neonates. In 2021, adults are dominating in the global dandruff treatment market as dandruff affects 50% of adults over different time periods primarily due to fungus infection, dry scalp and sebum production. Moreover, the number of adults affected by dandruff is very high as compared to pediatrics and neonates. Hence, adults are the primary users of dandruff treatment products.
  • On the basis of gender, the dandruff treatment market is segmented into male, female. In 2021, the male population is dominating in the global dandruff treatment market as in addition to fungus and dryness, higher sebum levels are also associated with the condition. Hence, more men are affected with dandruff as compared to women. This can be attributed to the changes in the activity of the sebaceous (oil) glands in the skin, such as the hike in sebum production around adolescence, increasing its likelihood.
  • On the basis of end-user, the dandruff treatment market is segmented into home care, dermatology centres, specialty clinics, others. In 2021, homecare is dominating in the global dandruff treatment market due to the self-administration nature of most products. The symptoms are easily recognizable and not medically detrimental. Hence, affected individuals tend to take care of themselves in most cases.
  • On the basis of distribution type, the dandruff treatment market is segmented into supermarkets/hypermarkets, convenience stores, pharmacies, retail stores, online stores, others. In 2021, supermarkets /hypermarkets are dominating in the market as the sources of the highest sales of consumer products. These establishments have large varieties of dandruff treatment products ranging from simplest products to premium products and the consumer can choose as per requirement. As a result, consumers prefer supermarkets /hypermarkets due to the availability of choices.

Dandruff Treatment Market Country Level Analysis

The dandruff treatment market is analysed and market size information is provided by type, mode of prescription, product, drug type, age group, gender, end-user and distribution type.

The countries covered in the dandruff treatment market report are the U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Poland, Turkey, Switzerland, Netherlands, Belgium, Hungary, Austria, Norway, Ireland, Lithuania, Rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, South Africa, Saudi Arabia, UAE, Israel, Egypt and Rest of Middle East and Africa.

The U.S. in North America has the highest household spending in the world and offers trade agreements with several countries making it the largest market for consumer products including dandruff treatment products. China is expected to dominate in the market in the Asia-Pacific market. China is one of the leading countries in the world with rapidly increasing product usage and treatment rate with rising awareness regarding Malassezia species. Germany in Europe is expected to grow with the most promising growth rate in the forecast period of 2021 to 2028 with changing lifestyle and growing urbanization.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Strategic Initiatives by manufacturers is Creating New Opportunities for Players in the Dandruff Treatment Market

The dandruff treatment market also provides you with detailed market analysis for every country growth in the aesthetic industry with dandruff treatment product sales, the impact of advancement in the dandruff treatment and changes in regulatory scenarios with their support for the dandruff treatment market. The data is available for the historic period 2010 to 2018.

Competitive Landscape and Dandruff Treatment Market Share Analysis

Dandruff treatment market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the dandruff treatment market.

The major companies providing dandruff treatment are Alliance Pharma PLC, Arcadia Consumer Healthcare, Vyome Therapeutics Inc., ACTICON LIFE SCIENCES, JOHN PAUL MITCHELL SYSTEMS, Johnson & Johnson Consumer Inc. (A Subsidiary of Johnson & Johnson Services, Inc.), JĀSÖN Natural Products, Inc. (A Subsidiary of Hain Celestial), Cipla Inc., Nikole Kozemetics, PHYTO, DABUR, Glenmark Pharmaceuticals Limited, Kao Corporation, L’OCCITANE EN PROVENCE INTERNATIONAL SA. (A Subsidiary of Groupe L’OCCITANE), PROCTER & GAMBLE, Philip Kingsley Products Ltd., Unilever, HENKEL AG & CO. KGAA, L’OREAL S.A., SOVEREIGN CHEMICALS & COSMETICS, M.M. AYURVEDIC (P) LTD., Arion Healthcare, Viencee Cosmatics, Sebapharma, AVON Beauty Products India Pvt Ltd, among others among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the dandruff treatment market.

  • In February 2019, Dabur launched two newproducts in the existing product portfolioof hair care products. This new productfound enhanced the company’s productportfolio and boosted the company’s revenue.

Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the dandruff treatment market which also provides the benefit for organisation to improve their offering for dandruff treatment market.

Global Dandruff Treatment Market

Source

Recent Posts

Scalp Microneedling Market

Scalp Microneedling Market

Global Scalp Microneedling Market Report 2020

The Scalp Microneedling market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period.

The global Scalp Microneedling market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Scalp Microneedling market. The report focuses on well-known providers in the global Scalp Microneedling industry, market segments, competition, and the macro environment._x000D_
_x000D_

Under COVID-19 Outbreak, how the Scalp Microneedling Industry will develop is also analyzed in detail in Chapter 1.7 of the report._x000D_

In Chapter 2.4, we analyzed industry trends in the context of COVID-19._x000D_

In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets._x000D_

In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries._x000D_

In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out._x000D_
_x000D_

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players._x000D_
_x000D_

Key players in the global Scalp Microneedling market covered in Chapter 4:_x000D_

zcalp
Lotus
Yonghe Hair Transplant
_x000D_

In Chapter 11 and 13.3, on the basis of types, the Scalp Microneedling market from 2015 to 2026 is primarily split into:_x000D_
Under 0.25 mm
25mm-0.3mm
75mm-1.0mm
1.0mm-1.5mm
Above 1.5mm
_x000D_

In Chapter 12 and 13.4, on the basis of applications, the Scalp Microneedling market from 2015 to 2026 covers:_x000D_
Hair Transplant
Boost Hair
Others
_x000D_

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:_x000D_

North America (Covered in Chapter 6 and 13)_x000D_
United States_x000D_
Canada_x000D_
Mexico_x000D_
Europe (Covered in Chapter 7 and 13)_x000D_
Germany_x000D_
UK_x000D_
France_x000D_
Italy_x000D_
Spain_x000D_
Russia_x000D_
Others_x000D_
Asia-Pacific (Covered in Chapter 8 and 13)_x000D_
China_x000D_
Japan_x000D_
South Korea_x000D_
Australia_x000D_
India_x000D_
Southeast Asia_x000D_
Others_x000D_
Middle East and Africa (Covered in Chapter 9 and 13)_x000D_
Saudi Arabia_x000D_
UAE_x000D_
Egypt_x000D_
Nigeria_x000D_
South Africa_x000D_
Others_x000D_
South America (Covered in Chapter 10 and 13)_x000D_
Brazil_x000D_
Argentina_x000D_
Columbia_x000D_
Chile_x000D_
Others_x000D_
_x000D_

Years considered for this report:_x000D_

Historical Years: 2015-2019_x000D_
Base Year: 2019_x000D_
Estimated Year: 2020_x000D_
Forecast Period: 2020-2026

Global Scalp Microneedling Market Report 2020

Source

Recent Posts